CompletedNCT00634062
Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
It focuses on personality disorders and currently lists study information in the United States.
Personality disorders, Borderline personalityDrugFrom 18 Years to 64 Years
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Belmont, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateDecember 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 28
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT00634062
- Official title
- Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
Recruitment & locations
CompletedBelmont
Registry details
Registry conditions (original wording)
Borderline Personality Disorder
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine and Placebo.
Who was this study for?
Listed age limits: 18 years to 64 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT02507206
A D1 Agonist For Working Memory
This study is completed. It focuses on personality disorders and currently lists study information in the United States.
CompletedNCT04566601
A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder
This study is completed in the United States, in Australia, in France, .... It focuses on Personality disorders.
CompletedNCT04100096
A study of Brexpiprazole in the Treatment of Borderline Personality Disorder
This study is completed. It focuses on personality disorders and currently lists study information in Spain, Ukraine, and the United States.